3543 results for «2099»

Filter By

3543 results

Will PARTNER-3 and Evolut low-risk trials change my practice?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.

Will PARTNER-3 and Evolut low-risk trials change my practice?

Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet

19 Nov 2019 – From PCR London Valves 2019

Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!

Controversy - Challenges

Innovations in transcatheter tricuspid valve intervention

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the innovations in transcatheter tricuspid valve intervention: discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.

Innovations in transcatheter tricuspid valve intervention

TAVI: management of unusual complications

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...

TAVI: management of unusual complications

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

18 Nov 2019 – From PCR London Valves 2019

Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France

Transcatheter edge-to-edge

PCI optimisation: OCT and physiology in a complex multivessel disease case

18 Dec 2019 – From GulfPCR-GIM 2019

The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).

The key objectives of this case are:

  1. Utility of FFR in physiological assessment of a...
PCI optimisation: OCT and physiology in a complex multivessel disease case

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

Interactive Case Corner 4 - Wandering stent

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover the case of a high-risk patient accepted for LM and multivessel PCI, and learn more about the transulnar approach strategy and benefits.

Interactive Case Corner 4 - Wandering stent

Interactive Case Corner 5 - Coronary CTO & ACS NSTEMI

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover two clinical cases on coronary CTO and ACS NSTEMI, and learn how to reduce radiation exposure to the patient during the procedure.

Interactive Case Corner 5 - Coronary CTO & ACS NSTEMI

Interactive Case Corner 6 - SCAD, LMS lesions & stent thrombosis

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn from complex clinical cases, how to manage challenging scenarios and complications, such as SCAD in three different vessels, acute stent thrombosis, LMS lesions, and more!

Interactive Case Corner 6 - SCAD, LMS lesions & stent thrombosis

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn from challenging clinical cases how to manage various complications, such as SVG thrombosis in STEMI, twisted coronary catheter, total stent loss and more!

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice

Complex and challenging cases II

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!

Complex and challenging cases II

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

Novel approach in the management of severely calcified lesions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.

Novel approach in the management of severely calcified lesions

All you need to know to start optimising outcomes in PCI: OCT and physiology

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...

All you need to know to start optimising outcomes in PCI: OCT and physiology

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

Improving patient access and clinical outcomes for valvular heart disease

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.

Improving patient access and clinical outcomes for valvular heart disease
Didn’t find what you were looking for?